David J Kuter (H Al-Samkari, Hanny Al-Samkari)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 79

Top Topics

Clinical Practice

Iron Deficiency

Aortic Valve Replacement

Top Venues

American journal of hematology

British journal of haematology

Nature reviews. Nephrology

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
David J Kuter, James B Bussel
Common-sense combination therapy in refractory immune thrombocytopaenia. British journal of haematology (2023)
Andrew B Song, David J Kuter
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert review of hematology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
Brody Foy, Jonathan A Stefely, Pavan K Bendapudi, Robert P Hasserjian, David J Kuter, Abner Louissaint, Megan Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins, Hasmukh Patel, Chhaya Patel, Nikita Patel, Samantha Ho, Richard M Kaufman, Walter 'Sunny' Dzik, John M Higgins, Robert S Makar
Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight. Blood advances (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology (2023)
David J Kuter, Ellis J Neufeld
Novel therapeutics and future directions for refractory immune thrombocytopenia. British journal of haematology 203 (1) (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
Roxana Ola, Josefien Hessels, Adrienne M Hammilll, Cassi Friday, Marianne S Clancy, David J Kuter, Stryder M Meadows, Vivek N Iyer, Rosemary J Akhurst
Executive summary of the 14th HHT international scientific conference. Angiogenesis (2023)
David J Kuter
Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia. Journal of internal medicine (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
Zain M Virk, T Lee Richardson, David J Kuter
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia. Journal of thrombosis and thrombolysis (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology 19 (4) (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology (2023)
David J Kuter, Debbie Jiang, Terry Gernsheimer, Howard Liebman, Susie Lee, Matthew Wojdyla, Michael Vredenburg, Adam Cuker
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. British journal of haematology 197 (3) (2022)
David J Kuter
Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Nathan W Watson, Seth A Wander, Joseph J Shatzel, David J Kuter
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer. Cancer 128 (17) (2022)
Andrew B Song, David J Kuter
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. Expert review of hematology 15 (10) (2022)
David J Kuter
Platelet clump visible to the naked eye in type 2B von Willebrand disease. Blood 138 (25) (2022)
Orly Leiva, Umberto Campia, Julia Snyder, Briana M Barns, Samantha Rizzo, Candrika D Khairani, Andrew Brunner, David J Kuter, Rebecca Karp Leaf, Rachel P Rosovsky, Katayoon Goodarzi, Larissa Bornikova, Amir Fathi, Samuel Z Goldhaber, Gabriela Hobbs, Gregory Piazza
Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Andrew B Song, David J Kuter
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia. Expert review of clinical immunology 18 (8) (2022)
David J Kuter, Whitney Eng
A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Therapeutic advances in COVID-19. Nature reviews. Nephrology (2022)
Zain M Virk, Andrew B Song, Yousef R Badran, David J Kuter
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement. Journal of thrombosis and thrombolysis 54 (2) (2022)
Abraham Z Cheloff, David J Kuter
Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies. Platelets 33 (8) (2022)
Nardeen Essam Ayad, Rachael F F Grace, David J Kuter, David J Kuter
Long-Term Risk of Developing Immune Thrombocytopenia and Hematologic Neoplasia in Adults with Mild Thrombocytopenia. Blood (2022)
David J Kuter, Frédéric Galactéros, Andreas Glenthoej, Jennifer A Rothman, Oliver Andres, Rachael F Grace, Marta Morado-Arias, D Mark Layton, Koichi Onodera, Madeleine Verhovsek, Wilma Barcellini, Satheesh Chonat, Malia P Judge, Erin Zagadailov, Rengyi Xu, Peter Hawkins, Vanessa Beynon, Sarah Gheuens, Eduard J van Beers, null null
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. The New England journal of medicine 386 (15) (2022)
David J Kuter, John A Glaspy, Robert T Means, Glenn M Chertow, Michael Auerbach
Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of internal medicine 175 (11) (2022)
Nathan W Watson, David J Kuter
Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. Journal of thrombosis and haemostasis : JTH 19 (8) (2021)
Abraham Z Cheloff, Andrew B Song, Kristin M D'Silva, David J Kuter
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia. Journal of thrombosis and thrombolysis (2021)
David J Kuter, Shruti Gupta, Rebecca Karp Leaf, Wei Wang, Rachel P Rosovsky, Samantha K Brenner, Salim Salim Hayek, Hanna Berlin, Rajat Kapoor, Shahzad Shaefi, Michal L Melamed, Anne Sutherland, Jared Radbel, Adam Green, Brian T Garibaldi, Anand Srivastava, Amanda Leonberg-Yoo, Alexandre M Shehata, Jennifer E Flythe, Arash Rashidi, Nitender Goyal, Lili Chan, Kusum S Mathews, S Susan Hedayati, Rajany Dy, Stephanie M Toth-Manikowski, Jingjing Zhang, Mary Mallappallil, Roberta E Redfern, Amar D Bansal, Samuel A P Short, Mark G Vangel, Andrew J Admon, Matthew W Semler, Kenneth A Bauer, Miguel A Hernán, David E Leaf, null null
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Annals of internal medicine 174 (5) (2021)
Andrew B Song, Rahul Sakhuja, Nancy M Gracin, Ronald Weinger, Raj S Kasthuri, David J Kuter
Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome. Blood advances 5 (19) (2021)
Eun-Ju Lee, David J Kuter
TPO versus TPO: the good, the bad, and the to be determined. British journal of haematology 195 (5) (2021)
Andrew B Song, Katayoon Goodarzi, Rebecca Karp Leaf, David J Kuter, David J Kuter
Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. American journal of hematology 96 (12) (2021)
David J Kuter
Recognition and management of vascular lesions in von Willebrand disease. Journal of thrombosis and haemostasis : JTH 19 (9) (2021)
Zain M Virk, Arpan A Patel, Rebecca K Leaf, David J Kuter
Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia. American journal of hematology 96 (12) (2021)
David J Kuter, Eduard J van Beers
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Therapeutic advances in hematology 12 (2021)
David J Kuter, Eduard J van Beers, D Holmes Morton, Stefan Eber, Satheesh Chonat, Kevin H M Kuo, Nina Kollmar, Heng Wang, Vicky Breakey, Sujit Sheth, Mukta Sharma, Peter W Forbes, Robert J Klaassen, Rachael F F Grace
Health-Related Quality of Life and Fatigue in Children and Adults with Pyruvate Kinase Deficiency. Blood advances (2021)
Emily M Harris, Kirsty Hillier, David J Kuter, Laura Berbert, Rachael F F Grace
Response to rituximab in children and adults with immune thrombocytopenia (ITP). Research and practice in thrombosis and haemostasis 5 (6) (2021)
Albert K Park, Anem Waheed, Deborah A Forst, David J Kuter
Characterization and Prognosis of Temozolomide-Induced Aplastic Anemia in Patients with Central Nervous System Malignancies. Neuro-oncology (2021)
Joseph G Parambil, James R Gossage, Keith R McCrae, Troy D Woodard, K V Narayanan Menon, Kasi L Timmerman, Douglas P Pederson, Dennis L Sprecher, David J Kuter
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Angiogenesis (2021)
Eun-Ju Lee, Marina Beltrami Moreira, David J Kuter, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig M Kessler, Caroline Kruse, Andrew D Leavitt, Alfred Ian Lee, Howard Allen Liebman, Adrian C Newland, Ashley E Ray, Michael D Tarantino, Jecko Thachil, David J Kuter, Douglas B Cines, James B Bussel
SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients. Blood (2021)
David J Kuter, Rebecca Karp Leaf, Katayoon Goodarzi
Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Annals of internal medicine 174 (11) (2021)
Sanjay R V Gadi, Patricia A R Brunker, David J Kuter, David B Sykes, Rebecca R Saff, Janet Lo, Pavan Bendapudi, David E Leaf, Rebecca Karp Leaf
Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine. Transfusion 61 (11) (2021)
Nardeen Essam Ayad, Rachael F F Grace, David J Kuter
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials. Pediatric blood & cancer 69 (3) (2021)
Fei Song, David J Kuter
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice. Journal of blood medicine 12 (2021)
David J Kuter, Alexandria Cronin, Donald M Arnold, Francesco Rodeghiero, Rachael F F Grace
Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology. Journal of thrombosis and haemostasis : JTH 19 (9) (2021)
David J Kuter, Arpan A Patel
How to focus our efforts in improving prognostic disclosure in oncology. Cancer 126 (11) (2020)
David J Kuter, Rakhi P Naik, Neil A Zakai
A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Research and practice in thrombosis and haemostasis 4 (8) (2020)
David J Kuter, Stacy E Croteau
Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2020)
Hanny Al-Samkari, Rachael F Grace, David J Kuter
The role of romiplostim for pediatric patients with immune thrombocytopenia. Therapeutic advances in hematology 11 (2020)
David J Kuter, Hasan A Albitar, Scott E Olitsky, Marianne S Clancy, Vivek N Iyer
An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
David J Kuter, Eduard J van Beers, D Holmes Morton, Wilma Barcellini, Stefan W Eber, Bertil Glader, Hassan M Yaish, Satheesh Chonat, Kevin H M Kuo, Nina Kollmar, Jenny M Despotovic, Dagmar Pospíšilová, Christine M Knoll, Janet L Kwiatkowski, Yves D Pastore, Alexis A Thompson, Marcin W Wlodarski, Yaddanapudi Ravindranath, Jennifer A Rothman, Heng Wang, Susanne Holzhauer, Vicky R Breakey, Madeleine M Verhovsek, Joachim Kunz, Sujit Sheth, Mukta Sharma, Melissa J Rose, Heather A Bradeen, Melissa N McNaull, Kathryn Addonizio, Hasan Al-Sayegh, Wendy B London, Rachael F F Grace
Characterization of the severe phenotype of pyruvate kinase deficiency. American journal of hematology (2020)
Marie E Faughnan, Johannes J Mager, Steven W Hetts, Valerie A Palda, Kelly Lang-Robertson, Elisabetta Buscarini, Erik Deslandres, Raj S Kasthuri, Andrea Lausman, David Poetker, Felix A Ratjen, Mark S Chesnutt, Marianne S Clancy, Kevin J Whitehead, David J Kuter, Murali M Chakinala, Miles B Conrad, Daniel Cortes, Claudia Crocione, Jama Darling, Els de Gussem, Carol Derksen, Sophie Dupuis-Girod, Patrick Foy, Urban W Geisthoff, James R Gossage, Adrienne M Hammilll, Ketil Heimdal, Katharine Henderson, Vivek N Iyer, Anette Drøhse Kjeldsen, Masaki Komiyama, Kevin Korenblatt, Jamie McDonald, Jack McMahon, Justin P McWilliams, Mary E Meek, Meir Mei Zahav, Scott Olitsky, Sara Palmer, Rose Pantalone, Jay F Piccirillo, Beth Plahn, Mary E M Porteous, Marco C Post, Ivan Radovanovic, Paul J Rochon, Josanna Rodriguez-Lopez, Carlo Sabba, Marcelo Martín Serra, Claire L Shovlin, Dennis Sprecher, Andrew J White, Ingrid Winship, Roberto Zarrabeitia
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of internal medicine 173 (12) (2020)
Abraham Z Cheloff, David J Kuter, David J Kuter
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features. Research and practice in thrombosis and haemostasis 4 (5) (2020)
Orly Leiva, Jean M Connors, David J Kuter
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers 12 (7) (2020)
David J Kuter, Kathryn Addonizio, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A Thompson, Kevin H M Kuo, Yaddanapudi Ravindranath, Heng Wang, Jennifer A Rothman, Janet L Kwiatkowski, Charles Kung, Penelope A Kosinski, Hasan Al-Sayegh, Wendy B London, Rachael F F Grace
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. British journal of haematology 192 (6) (2020)
David J Kuter, Fei Song, Elizabeth M Van Cott, David J Kuter, Rachel Rosovsky
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). American journal of hematology 95 (12) (2020)
David J Kuter
New therapeutic horizons in Wiskott-Aldriech syndrome. British journal of haematology 192 (2) (2020)
Andrew B Song, David J Kuter, David J Kuter
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. American journal of hematology (2020)
David J Kuter
Striving for full disclosure-An intergenerational challenge. Cancer 126 (6) (2019)
David J Kuter, Hasan A Albitar, Scott E Olitsky, Marianne S Clancy, Vivek N Iyer
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers. Orphanet journal of rare diseases 14 (1) (2019)
David J Kuter, David J Kuter
Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet count. British journal of haematology 187 (3) (2019)
David J Kuter, Ariela L Marshall, Katayoon Goodarzi, David J Kuter
Romiplostim for the management of perioperative thrombocytopenia. British journal of haematology 182 (1) (2018)
David J Kuter, David J Kuter
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. British journal of haematology 183 (2) (2018)
David J Kuter, Elizabeth M Van Cott, David J Kuter
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Annals of hematology 98 (3) (2018)
David J Kuter, Gregory D Snyder, Sarah Nikiforow, Sara M Tolaney, Rachel A Freedman, Julie-Aurore Losman
Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism. Journal of medical genetics 56 (1) (2018)
David J Kuter, Jean M Connors
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis. Cancers 10 (8) (2018)
David J Kuter, Rachael F Grace, Jean M Connors
Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and thrombolysis 46 (1) (2018)
David J Kuter, A Kritharis, J M Rodriguez-Lopez, D J Kuter
Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. Journal of internal medicine 285 (2) (2018)
David J Kuter, Jean M Connors
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability. American journal of hematology 93 (6) (2018)
David J Kuter, David J Kuter
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia. British journal of clinical pharmacology 84 (11) (2018)
David J Kuter, David J Kuter
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. American journal of hematology 93 (12) (2018)
David J Kuter
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear. BMJ evidence-based medicine 24 (3) (2018)